Ledger.Open graph →

SEC Form D · filed November 4, 2021

EYEGATE PHARMACEUTICALS INC

Offering

—

Sold

$67K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WALTHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Brian Strem · Waltham, MAExec · Director Stephen From · Waltham, MAExec · Director Kenneth Gayron · Waltham, MADirector Praveen Tyle · Waltham, MADirector Sarah Romano · Waltham, MAExec Aron Shapiro · Waltham, MADirector Paul Chaney · Waltham, MADirector Matthew Wampler · COLLEGEVILLE, PADirector Yaron Naymark · Westport, CTExec · Director David Wurtzbacher · Woodbridge, VAExec Justin Jory · Woodbridge, VADirector Rodney D. Brown · LEESBURG, VAExec · Director Randy H. Hopkins · Meridian, IDDirector Shravan Parsi · Austin, TXDirector Eric Daniels · London, United KingdomExec Amir Nashat · CAMBRIDGE, MADirector Paula Ragan · CAMBRIDGE, MADirector Richard Young · CAMBRIDGE, MAExec Josh Mandel-Brehm · CAMBRIDGE, MAExec · Director Daniel Kapnick · Chicago, ILDirector Paul Shufro · Wilton, CTDirector Jeffery Birch · Chicago, ILExec · Director Eric Daniels · Encinitas, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗